Fig. 4.

Geometric mean (with 95% CI) plasma concentrations versus scheduled time for i) bimekizumab delivered via a single 2 mL injection using a safety syringe (BKZ-SSy-1 × 2 mL; n = 18) and BKZ delivered via two 1 mL injections using an SSy (BKZ-SSy-2 × 1 mL; n = 18), and ii) BKZ delivered via a single 2 mL injection using an auto-injector (BKZ-AI-1 × 2 mL; n = 17) and BKZ delivered via two 1 mL injections using an AI (BKZ-AI-2 × 1 mL; n = 18) in UP0068. 1 × 2 mL a single 2 mL injection, 2 × 1 mL, two 1 mL injections, AI auto-injector, BKZ bimekizumab, CI confidence interval, SSy safety syringe